Fundamental Data for CVD

Covance Inc. is a leading contract research organization providing a widerange of product development services on a worldwide basis to thepharmaceutical, biotechnology and medical device industries. The company also provide health economics and outcomes services for managed care organizations, hospitals and other health care providers and laboratory testing services to the chemical, agrochemical and food industries.

# Employees: 9600

Address: 210 Carnegie Center,Princeton,NJ,USA

Phone: 609 452-4440

Fax: 609 452-4769

Website: www.covance.com

Email: investigaters@covance.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Joseph L. Herring (Chmn.; C.E.O.)

William E. Klitgaard (Corp. Sr. V.P.; C.F.O.)

Michele A. Kennedy (Corp. Sr. V.P.; Contr.; Chief Acctg. Off.)

Kathleen G. Bang (Dir.)

Robert Barchi (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/27/2010

Mean EPS (Next Qtr): $0.65

Mean EPS (Year): $2.63

Mean Estimate(Long Term): $13.14

P/E Ratio(Based on EPS estimate): 20.270

Number of Estimates: 14

Shares Performance

Period	CVD	Compare to S&P
YTD	15.79 %	-4.18 %
4 Weeks	3.13 %	-2.09 %
12 Weeks	-1.82 %	-8.58 %

Shares Information

Analyst Coverage: Y

Avg Volume: 532106

Shares Outstanding: 63M

Market Cap: $3.41B

52 Week High: $58.56

52 Week Low: $32.99

P/E Ratio: 19.890

PEG Ratio: 1.540

Split: On 1/1/1990 CVD split by factor of 0.250

Earnings Performance

EPS Growth in Last Quarter: 1.52 %

EPS Growth in Last Year: -16.25 %

Sales Growth in Last Quarter: 0.90 %

Sales Growth in Last Quarter: 5.63 %

Financials

Qtr Book Value: $2.47

Cash Flow/Share: $12.70

Change in Payout Ratio: 0.000

Price/Sales: 1.780